Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from Rhythm Biosciences Ltd. ( (AU:RHY) ) is now available.
Rhythm Biosciences Ltd has requested a trading halt on its securities pending an announcement related to a capital raise. This halt will remain in place until the announcement is made or until normal trading resumes on August 18, 2025. The trading halt is a strategic move to manage the dissemination of information regarding the capital raise, which could have significant implications for the company’s financial strategy and stakeholder interests.
More about Rhythm Biosciences Ltd.
Rhythm Biosciences Ltd is a company operating in the biotechnology industry, focusing on developing diagnostic technologies. The company is based in Australia and is listed on the Australian Securities Exchange (ASX) under the ticker RHY.
Average Trading Volume: 644,466
Technical Sentiment Signal: Buy
Current Market Cap: A$30.54M
See more data about RHY stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money